[1]
Loap, P. et al. 2022. Cardiotoxicity model-based patient selection for Hodgkin lymphoma proton therapy. Acta Oncologica. 61, 8 (Aug. 2022), 979–986. DOI:https://doi.org/10.1080/0284186X.2022.2084639.